CLINICAL_TRIALS
trial_result
· 2024-10-23
Clinical Trial Update: A Study to Test the Efficacy and Safety of Bimekizumab in the Treatment of Subjects With Active Psoriatic Arthritis [Phase 3]
Summary
Phase 3 trial of bimekizumab for active psoriatic arthritis completed, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: UCB Biopharma SRL | Conditions: Psoriatic Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2024-10-23